Professor Clive Page

Joint Head of Institute of Pharmaceutical Science, Professor of Pharmacology at King's College London (KCL)

Joint Head of Institute of Pharmaceutical Science, Professor of Pharmacology, Kings College London

Clive Page is a Professor of Pharmacology, King’s College London, Joint Head of the Institute of Pharmaceutical Science and Director of the Sackler Institute of Pulmonary Pharmacology, King’s College London. Clive’s main research interests are in the pharmacology of inflammation and respiratory disease and he has published over 250 scientific papers.

Clive is also the co-founder and Chairman of the Board of Verona Pharma plc, an AIM listed Company developing new drugs for the treatment of Respiratory Diseases. He is also a Non Executive Director of Helperby Therapeutics plc, a spin out Company from St. George’s Hospital Medical School developing novel anti-infective drugs and of Babraham Biotechnology Ltd, as well as being a Trustee of the Babraham Institute in Cambridge. Clive started his early career in the Pharmaceutical Industry at Sandoz Ltd, Basel, Switzerland and regularly consults to both the Pharmaceutical and Biotech Industry.

Clive is also the Chairman of the Animal Science Group of the Society of Biology and a Council Member of Understanding Animal Research and has contributed widely to the public debate about the use of animals in Research.